CONMED Corp — Director's Dealing 2022

Mar 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-03-15

Reporting Person: Hartman Curt R (Director, President, CEO and Chair)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-15	Common Stock	S	2500	$138.429	Disposed	7449	Direct
2022-03-15	Common Stock	M	15000	$41.93	Acquired	22449	Direct
2022-03-15	Common Stock	F	8650	$138.85	Disposed	13799	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-15	Options To Purchase Common Stock	$41.93	M	15000	Disposed	2027-03-01	Common Stock (15000)	Direct

Footnotes

F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.